Reconstitution of the human ovarian tumor-microenvironment in CD34-transplanted NOD-Scid-IL2Rγc null (NSG) mice

被引:0
|
作者
Walter, Marc [1 ]
Mookerjee, Ananda [1 ]
Nunez-Cruz, Selene [1 ]
Fang, Chongyun [1 ]
Facciabene, Andrea [1 ]
Coukos, George [1 ]
Scholler, Nathalie [1 ]
Danet-Desnoyers, Gwenn [1 ]
机构
[1] Univ Penn, Philadelphia, PA 19104 USA
关键词
D O I
10.1158/1538-7445.AM2011-LB-286
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
LB-286
引用
收藏
页数:2
相关论文
共 50 条
  • [31] The differentiative and regenerative properties of human hematopoietic stem/progenitor cells in NOD-SCID/IL2rγnull mice
    Ishikawa, F.
    Saito, Y.
    Yoshida, S.
    Harada, M.
    Shultz, L. D.
    HUMANIZED MICE, 2008, 324 : 87 - 94
  • [32] Ex vivo fucosylation improves human cord blood engraftment in NOD-SCID IL-2Rγnull mice
    Robinson, Simon N.
    Simmons, Paul J.
    Thomas, Michael W.
    Brouard, Nathalie
    Javni, Jeannie A.
    Trilok, Suprita
    Shim, Jae-Seung
    Yang, Hong
    Steiner, David
    Decker, William K.
    Xing, Dongxia
    Shultz, Leonard D.
    Savoldo, Barbara
    Dotti, Gianpietro
    Bollard, Catherine M.
    Miller, Leonard
    Champlin, Richard E.
    Shpall, Elizabeth J.
    Zweidler-McKay, Patrick A.
    EXPERIMENTAL HEMATOLOGY, 2012, 40 (06) : 445 - 456
  • [33] Attenuation of graft-versus-host-disease in NOD scid IL-2R-/- (NSG) mice by ex vivo modulation of human CD4+ T cells
    Hilger, Nadja
    Glaser, Jakob
    Mueller, Claudia
    Halbich, Christoph
    Mueller, Anne
    Schwertassek, Ulla
    Lehmann, Joerg
    Ruschpler, Peter
    Lange, Franziska
    Boldt, Andreas
    Stahl, Lilly
    Sack, Ulrich
    Oelkrug, Christopher
    Emmrich, Frank
    Fricke, Stephan
    CYTOMETRY PART A, 2016, 89A (09) : 803 - 815
  • [34] RAPAMYCIN DELAYS XENOGENEIC ACUTE GRAFT VERSUS HOST DISEASE (AGVHD) IN NOD/SCID/IL2RγNULL (NSG) MICE: IMPACT OF REGULATORY T CELLS
    Bruck, F.
    Baron, F.
    Dubois, S.
    Briquet, A.
    Hanon-Absil, M.
    Belle, L.
    Menten, C.
    Beguin, Y.
    Humblet-Baron, S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S332 - S332
  • [35] Human IL-10 exacerbates graft versus host disease in NOD-scid IL2rγcnull mice transplanted with human PBMCs
    Abraham, Sojan
    Choi, Jang Gi
    Manjunath, N.
    Shankar, Premlata
    JOURNAL OF IMMUNOLOGY, 2014, 192
  • [36] Intra-bone marrow transplantation of human CD34+ cells into NOD/LtSz-scid IL-2rγnull mice permits multilineage engraftment without previous irradiation
    Bueno, Clara
    Montes, Rosa
    de La Cueva, Teresa
    Gutierrez-Aranda, Ivan
    Menendez, Pablo
    CYTOTHERAPY, 2010, 12 (01) : 45 - 49
  • [37] Intra-Bone Marrow Transplantation of Human CD34+ Cells into NOD/LTSZ-SCID IL2Rγ-Null Mice Permits Multilineage Engraftment Without Previous Irradiation
    Bueno, Clara
    Montes, Rosa
    de la Cueva, Teresa
    Gutierrez-Aranda, Ivan
    Menendez, Pablo
    HUMAN GENE THERAPY, 2009, 20 (09) : 1058 - 1058
  • [38] Successful engraftment of human skin and T cells in NOD-scid-IL2γr null mice for the investigation of human inflammatory skin responses
    Agarwal, P.
    Racki, W. J.
    Cuthbert, A.
    Brehm, M. S.
    Shultz, L. D.
    Greiner, D. L.
    Harris, J. E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2012, 132 : S4 - S4
  • [39] Regeneration of CD34+ BCR-ABL+ IL-3+ G-CSF+ cells in NOD/SCID and NOD/SCID-β2microglobulin null (β2M-/-) mice transplanted with chronic myeloid leukemia (CML) cells.
    Eisterer, W
    Jiang, X
    Glimm, H
    Lambie, K
    Shaw, G
    Lee, K
    Petzer, A
    Auewarakul, Y
    Caligiuri, M
    Barnett, M
    Eaves, C
    Eaves, A
    BLOOD, 2000, 96 (11) : 349A - 349A
  • [40] Long-term maintenance of skin immune system in a NOD-Scid IL2rγnull mouse model transplanted with human skin
    Soria, Angele
    Boccara, David
    Chonco, Louis
    Yahia, Nora
    Dufossee, Melody
    Cardinaud, Sylvain
    Moris, Arnaud
    Liard, Christelle
    Joulin-Giet, Alix
    Julithe, Marion
    Mimoun, Maurice
    Combadiere, Behazine
    Perrin, Helene
    EXPERIMENTAL DERMATOLOGY, 2014, 23 (11) : 850 - 852